Parasite | Eso | Sto | Cancer | ESD
001 | 101 | 201 | 301 | 401 | 501 | 601 | 701 | 801 | 901 | 1000
Á¶±âÀ§¾Ï Ä¡°í´Â ±Ë¾çÀÌ Á¶±Ý ±í¾î º¸ÀÌ°í ÁøÇ༺ À§¾Ï Ä¡°í´Â ¾à°£ ÀÛ´Ù°í »ý°¢Çß´ø ȯÀÚÀÔ´Ï´Ù.
¾Æ·¡·Î
¾Æ·¡·Î
¾Æ·¡·Î
¾Æ·¡·Î
¾Æ·¡·Î
Á¶±âÀ§¾Ï Ä¡°í´Â ±Ë¾çÀÌ Á¶±Ý ±í¾î º¸ÀÌ°í ÁøÇ༺ À§¾Ï Ä¡°í´Â ¾à°£ ÀÛ´Ù°í »ý°¢Çß´ø ȯÀÚÀÔ´Ï´Ù. Á¶Á÷°Ë»ç¿¡¼ poorly differentiated adenocarcinoma·Î ³ª¿Í ¼ö¼úÀ» ÇÏ¿´´Âµ¥ ÀÇ¿Ü·Î ¾Æ·¡¿Í °°Àº °á°ú¿´½À´Ï´Ù. ¹º°¡ Á¶±Ý ÀÌ»óÇÏ´Ù°í »ý°¢µÉ ¶§ Àß ³ª¿À´Â º´ÀÌ lymphoma³ª neuroendocrine tumorÀÔ´Ï´Ù.
Histologic type : neuroendocrine carcinoma, poorly differentiated
Size : 2.5x1.8 cm
Depth of invasion : invades muscularis propria (pT2)
Resection margin: free from carcinoma
Lymph node metastasis : metastasis to 4 out of 59 regional lymph nodes (pN2)
Lymphatic invasion : present
Venous invasion : present (intra-and extramural)
Perineural invasion : not identified
¾à°£ ´Ù¸¥ À̾߱âÁö¸¸ Á¾¾ç¿¡ ÀÇÇÏ¿© ħ¹üµÈ lymph node´Â 4°³¿´°í pN2·Î staging µÇ¾ú½À´Ï´Ù. °ú°Å¿¡´Â stagingÀÌ N1¿´´ø °ÍÀε¥ AJCC 7ÆÇ¿¡ µû¶ó stagingÀÌ ´Ù¼Ò ¹Ù²ï °ÍÀÔ´Ï´Ù. ÀúÈñ º´¿ø¿¡¼´Â 2010³â 4¿ù 1ÀϺÎÅÍ AJCC 7ÆÇ¿¡ µû¶ó stagingÇÏ°í ÀÖ½À´Ï´Ù.
2014. 6. 23. ÀÌÁØÇà